サマリー

アジア太平洋地域の便診断市場は、2023年から2030年にかけて7.1%のCAGRを記録すると予測されます。この新しい市場レポートは、歴史的な年2021年のデータを含み、計算の基準年は2022年で、予測期間は2023年から2030年です。

市場の細分化：

アジア太平洋地域の便診断市場、検査タイプ別（便潜血検査、便バイオマーカー検査、病原体検査、便抗原検査、便エラスターゼ検査、顕微鏡検査、その他検査）、製品タイプ別（機器、試薬）、モード別（ラボラトリーベース検査、ポイントオブケア検査）、アプリケーション（過敏性腸症候群、潰瘍性腸炎、クローン病、がん、下痢、痔、その他）、エンドユーザー（病院、診断センター、研究所、専門クリニック、学術機関・研究センター、その他）、流通チャネル（直接入札、小売販売、オンライン販売、その他）、国（日本、中国、韓国、インド、シンガポール、タイ、インドネシア、マレーシア、フィリピン、オーストラリア、ニュージーランド、ベトナム、台湾、ブルネイ、ネパール、バングラデシュ、スリランカ、パキスタン、香港、モルディブ、モンゴル、カンボジア、ラオス、その他のアジア太平洋） 産業動向と2030年までの予測

アジア太平洋地域の便診断市場の成長に寄与する主な要因としては、以下のものが挙げられます：

- 胃腸障害の有病率の増加
- ポイントオブケア型便診断装置の需要拡大
市場関係者
アジア太平洋地域の便診断市場を扱っている主な企業は以下の通りです：
- アボット社
- メリディアンバイオサイエンス株式会社
- BIOMERIEUX
- ベックマン・コールター社（ダナハー社子会社）
- DiaSorin S.p.A.
- ランメイ
- モルビオ・ダイアグノスティックス・ピーブイティー・リミテッド
- クィデル株式会社
- プレネティクス社（Prenetics Limited
- 積水ダイアグノスティックス（積水化学工業株式会社内）
- バイオベンダーグループ
- ライフサイン合同会社
- アルファ・サイエンティフィック・デザインズ(株)
- 栄研化学(株)
- SDバイオセンサー, INC.
- セノジェニックス株式会社
- トランスジェン・バイオテック株式会社
- アドバケアファーマ
- キビオン社
- 北京華源安邦科技有限公司

ページTOPに戻る

目次

TABLE OF CONTENTS
1 INTRODUCTION 30
1.1 OBJECTIVES OF THE STUDY 30
1.2 MARKET DEFINITION 30
1.3 OVERVIEW OF THE ASIA-PACIFIC STOOL DIAGNOSTIC MARKET 30
1.4 LIMITATIONS 32
1.5 MARKETS COVERED 32
2 MARKET SEGMENTATION 35
2.1 MARKETS COVERED 35
2.2 GEOGRAPHICAL SCOPE 36
2.3 YEARS CONSIDERED FOR THE STUDY 36
2.4 CURRENCY AND PRICING 36
2.5 DBMR TRIPOD DATA VALIDATION MODEL 37
2.6 MULTIVARIATE MODELLING 40
2.7 TEST TYPE LIFELINE CURVE 40
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 41
2.9 DBMR MARKET POSITION GRID 42
2.10 MARKET APPLICATION COVERAGE GRID 44
2.11 VENDOR SHARE ANALYSIS 45
2.12 SECONDARY SOURCES 46
2.13 ASSUMPTIONS 46
3 EXECUTIVE SUMMARY 47
4 PREMIUM INSIGHTS 50
4.1 PESTEL ANALYSIS 51
4.2 PORTER’S FIVE FORCES 52
5 INDUSTRY INSIGHTS 53
6 REGULATIONS 54
7 MARKET OVERVIEW 57
7.1 DRIVERS 59
7.1.1 INCREASING PREVALENCE OF GASTROINTESTINAL DISEASE 59
7.1.2 INCREASING PREVALENCE OF ESOPHAGEAL, COLORECTAL, AND GASTRIC CANCERS 59
7.1.3 RISING DEMAND FOR EARLY DISEASE DIAGNOSIS 60
7.2 RESTRAINTS 62
7.2.1 STRICT GOVERNMENT REGULATIONS 62
7.2.2 HIGH COST ASSOCIATED WITH STOOL DIAGNOSIS 63
7.3 OPPORTUNITIES 64
7.3.1 ADVANCEMENTS IN SAMPLE COLLECTION AND HANDLING FOR STOOL DIAGNOSTICS 64
7.3.2 RISING DEMAND FOR NON-INVASIVE OR MINIMAL INVASIVE STOOL DIAGNOSTICS 64
7.4 CHALLENGES 65
7.4.1 LACK OF SKILLED & CERTIFIED PROFESSIONALS 65
7.4.2 LACK OF STANDARDIZATION IN STOOL DIAGNOSTIC PROCEDURE 66
8 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY TEST TYPE 67
8.1 OVERVIEW 68
8.2 PATHOGEN TEST 71
8.2.1 H. PYLORI TEST 71
8.2.1.1 H. PYLORI ANTIGEN TEST 72
8.2.1.2 UREA BREATH TEST 72
8.2.2 C. DEFFCILE TEST 72
8.2.3 OVA & PARASITE TEST 72
8.2.4 ROTAVIRUS TEST 72
8.2.5 ADENOVIRUS TEST 72
8.2.6 SALMONELLA CULTURE TEST 72
8.2.7 CAMPYLOBACTER TEST 73
8.2.8 EHEC TEST 73
8.2.9 OTHERS 73
8.3 FECAL OCCULT BLOOD TEST 73
8.3.1 LATERAL FLOW IMMUNO-FOB TEST 74
8.3.2 IMMUNO-FOB AGGLUTINATION TEST 74
8.3.3 GUAIC FOB STOOL TEST 74
8.3.4 OTHERS 74
8.4 FECAL BIOMARKERS TEST 74
8.4.1 INFLAMMATORY BIOMARKERS TEST 75
8.4.1.1 FECAL CALPROTECTIN 75
8.4.1.2 FECAL LACTOFERRIN 75
8.4.1.3 OTHERS 75
8.4.2 CANCER BIOMARKERS TEST 76
8.4.2.1 COLOGUARD 76
8.4.2.2 M2 PK STOOL TEST 76
8.4.2.3 OTHERS 76
8.4.3 OTHERS 76
8.5 MICROSCOPY TEST 77
8.6 STOOL ANTIGEN TEST 77
8.7 FECAL ELASTASE TEST 77
8.8 OTHER TESTS 78
9 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE 79
9.1 OVERVIEW 80
9.2 REAGENTS 83
9.2.1 FECAL FLOAT SOLUTIONS 83
9.2.2 BUFFER SOLUTIONS 83
9.2.3 ABSOLUTE METHANOL 83
9.2.4 ACID ALCOHOL 84
9.2.5 OTHERS 84
9.3 INSTRUMENTS 84
9.3.1 FECALYZERS 85
9.3.2 DIGITAL SCALES 85
9.3.3 MICROSCOPES 85
9.3.4 MICROSCOPE SLIDES 85
9.3.5 MICROSCOPE COVER SLIPS 85
9.3.6 OTHERS 85
10 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY MODE 86
10.1 OVERVIEW 87
10.2 LABORATORY BASED TESTING 90
10.3 POINT OF CARE TESTING 90
11 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY APPLICATION 91
11.1 OVERVIEW 92
11.2 DIARRHEA 95
11.3 IRRITABLE BOWEL SYNDROME 95
11.4 HEMORRHOIDS 95
11.5 ULCERATIVE COLITIS 96
11.6 CANCER 96
11.6.1 COLORECTAL 97
11.6.2 COLON 97
11.6.3 OTHER 97
11.7 CROHN’S DISEASE 97
11.8 OTHERS 98
12 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY END USER 99
12.1 OVERVIEW 100
12.2 HOSPITALS 103
12.3 DIAGNOSTIC CENTERS 103
12.4 LABORATORIES 103
12.5 SPECIALTY CLINICS 104
12.6 ACADEMIC INSTITUTES AND RESEARCH CENTERS 104
12.7 OTHERS 105
13 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL 106
13.1 OVERVIEW 107
13.2 DIRECT TENDERS 110
13.3 RETAIL SALES 110
13.4 ONLINE SALES 110
13.5 OTHERS 111
14 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET BY REGION 112
14.1 ASIA-PACIFIC 112
14.1.1 CHINA 118
14.1.2 JAPAN 123
14.1.3 INDIA 128
14.1.4 SOUTH KOREA 133
14.1.5 AUSTRALIA 138
14.1.6 MALAYSIA 143
14.1.7 INDONESIA 148
14.1.8 PHILIPPINES 154
14.1.9 THAILAND 159
14.1.10 NEW ZEALAND 164
14.1.11 TAIWAN 169
14.1.12 VIETNAM 174
14.1.13 HONG KONG 179
14.1.14 SINGAPORE 184
14.1.15 PAKISTAN 189
14.1.16 BANGLADESH 194
14.1.17 SRI LANKA 199
14.1.18 CAMBODIA 204
14.1.19 NEPAL 209
14.1.20 MONGOLIA 214
14.1.21 LAOS 219
14.1.22 MALDIVES 224
14.1.23 BRUNEI 229
14.1.24 REST OF ASIA-PACIFIC 234
15 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: COMPANY LANDSCAPE 235
15.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 235
16 SWOT ANALYSIS 236
17 COMPANY PROFILE 237
17.1 EIKEN CHEMICAL CO., LTD. 237
17.1.1 COMPANY SNAPSHOT 237
17.1.2 REVENUE ANALYSIS 237
17.1.3 PRODUCT PORTFOLIO 238
17.1.4 RECENT DEVELOPMENT 238
17.2 QUIDEL CORPORATION 239
17.2.1 COMPANY SNAPSHOT 239
17.2.2 REVENUE ANALYSIS 239
17.2.3 PRODUCT PORTFOLIO 240
17.2.4 RECENT DEVELOPMENTS 240
17.3 BIOMERIEUX 241
17.3.1 COMPANY SNAPSHOT 241
17.3.2 REVENUE ANALYSIS 241
17.3.3 PRODUCT PORTFOLIO 242
17.3.4 RECENT DEVELOPMENTS 242
17.4 SD BIOSENSOR, INC. 243
17.4.1 COMPANY SNAPSHOT 243
17.4.2 REVENUE ANALYSIS 243
17.4.3 PRODUCT PORTFOLIO 244
17.4.4 RECENT DEVELOPMENTS 244
17.5 SEKISUI DIAGNOSTICS (A PART OF SEKISUI CHEMICAL CO. LTD.) 245
17.5.1 COMPANY SNAPSHOT 245
17.5.2 REVENUE ANALYSIS 245
17.5.3 PRODUCT PORTFOLIO 246
17.5.4 RECENT DEVELOPMENTS 246
17.6 ABBOTT 247
17.6.1 COMPANY SNAPSHOT 247
17.6.2 REVENUE ANALYSIS 247
17.6.3 PRODUCT PORTFOLIO 248
17.6.4 RECENT DEVELOPMENT 248
17.7 ADVACARE PHARMA 249
17.7.1 COMPANY SNAPSHOT 249
17.7.2 PRODUCT PORTFOLIO 249
17.7.3 RECENT DEVELOPMENTS 249
17.8 ALFA SCIENTIFIC DESIGNS, INC. 250
17.8.1 COMPANY SNAPSHOT 250
17.8.2 PRODUCT PORTFOLIO 250
17.8.3 RECENT DEVELOPMENTS 250
17.9 BECKMAN COULTER, INC. (SUBSIDIARY OF DANAHER) 251
17.9.1 COMPANY SNAPSHOT 251
17.9.2 REVENUE ANALYSIS 251
17.9.3 PRODUCT PORTFOLIO 252
17.9.4 RECENT DEVELOPMENTS 252
17.10 BEIJING HUAGEN ANBANG TECHNOLOGY CO., LTD. 253
17.10.1 COMPANY SNAPSHOT 253
17.10.2 PRODUCT PORTFOLIO 253
17.10.3 RECENT DEVELOPMENT 253
17.11 BIOVENDOR GROUP 254
17.11.1 COMPANY SNAPSHOT 254
17.11.2 PRODUCT PORTFOLIO 254
17.11.3 RECENT DEVELOPMENTS 254
17.12 CENOGENICS CORPORATION 255
17.12.1 COMPANY SNAPSHOT 255
17.12.2 PRODUCT PORTFOLIO 255
17.12.3 RECENT DEVELOPMENTS 255
17.13 DIASORIN S.P.A. 256
17.13.1 COMPANY SNAPSHOT 256
17.13.2 REVENUE ANALYSIS 256
17.13.3 PRODUCT PORTFOLIO 257
17.13.4 RECENT DEVELOPMENT 257
17.14 KIBION GMBH (A SUBSIDIARY OF OREXO AB) 258
17.14.1 COMPANY SNAPSHOT 258
17.14.2 REVENUE ANALYSIS 258
17.14.3 PRODUCT PORTFOLIO 259
17.14.4 RECENT DEVELOPMENTS 259
17.15 LIFESIGN LLC 260
17.15.1 COMPANY SNAPSHOT 260
17.15.2 PRODUCT PORTFOLIO 260
17.15.3 RECENT DEVELOPMENTS 260
17.16 MERIDIAN BIOSCIENCE INC. 261
17.16.1 COMPANY SNAPSHOT 261
17.16.2 REVENUE ANALYSIS 261
17.16.3 PRODUCT PORTFOLIO 262
17.16.4 RECENT DEVELOPMENT 262
17.17 MOLBIO DIAGNOSTICS PVT. LTD. 263
17.17.1 COMPANY SNAPSHOT 263
17.17.2 PRODUCT PORTFOLIO 263
17.17.3 RECENT DEVELOPMENT 263
17.18 PRENETICS LIMITED 264
17.18.1 COMPANY SNAPSHOT 264
17.18.2 REVENUE ANALYSIS 264
17.18.3 PRODUCT PORTFOLIO 265
17.18.4 RECENT DEVELOPMENT 265
17.19 RUNMEI 266
17.19.1 COMPANY SNAPSHOT 266
17.19.2 PRODUCT PORTFOLIO 266
17.19.3 RECENT DEVELOPMENTS 266
17.20 TRANSGEN BIOTECH CO., LTD. 267
17.20.1 COMPANY SNAPSHOT 267
17.20.2 PRODUCT PORTFOLIO 267
17.20.3 RECENT DEVELOPMENT 267
18 QUESTIONNAIRE 268
19 RELATED REPORTS 272

ページTOPに戻る

図表リスト

LIST OF TABLES
TABLE 1 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 70
TABLE 2 ASIA-PACIFIC PATHOGEN TEST IN STOOL DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 71
TABLE 3 ASIA-PACIFIC H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 72
TABLE 4 ASIA-PACIFIC FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 74
TABLE 5 ASIA-PACIFIC FECAL BIOMARKERS TEST IN STOOL DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 75
TABLE 6 ASIA-PACIFIC INFLAMMATORY BIOMARKERS TEST IN STOOL DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 75
TABLE 7 ASIA-PACIFIC CANCER BIOMARKERS TEST IN STOOL DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 76
TABLE 8 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 82
TABLE 9 ASIA-PACIFIC REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 83
TABLE 10 ASIA-PACIFIC INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 85
TABLE 11 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 89
TABLE 12 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 94
TABLE 13 ASIA-PACIFIC CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 97
TABLE 14 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 102
TABLE 15 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 109
TABLE 16 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 117
TABLE 17 CHINA STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 118
TABLE 18 CHINA PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 118
TABLE 19 CHINA H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 119
TABLE 20 CHINA FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 119
TABLE 21 CHINA FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 119
TABLE 22 CHINA INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 119
TABLE 23 CHINA CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 120
TABLE 24 CHINA STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 120
TABLE 25 CHINA REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 120
TABLE 26 CHINA INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 121
TABLE 27 CHINA STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 121
TABLE 28 CHINA STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 121
TABLE 29 CHINA CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 122
TABLE 30 CHINA STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 122
TABLE 31 CHINA STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 122
TABLE 32 JAPAN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 123
TABLE 33 JAPAN PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 123
TABLE 34 JAPAN H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 124
TABLE 35 JAPAN FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 124
TABLE 36 JAPAN FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 124
TABLE 37 JAPAN INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 124
TABLE 38 JAPAN CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 125
TABLE 39 JAPAN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 125
TABLE 40 JAPAN REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 125
TABLE 41 JAPAN INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 126
TABLE 42 JAPAN STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 126
TABLE 43 JAPAN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 126
TABLE 44 JAPAN CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 127
TABLE 45 JAPAN STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 127
TABLE 46 JAPAN STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 127
TABLE 47 INDIA STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 128
TABLE 48 INDIA PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 128
TABLE 49 INDIA H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 129
TABLE 50 INDIA FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 129
TABLE 51 INDIA FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 129
TABLE 52 INDIA INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 130
TABLE 53 INDIA CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 130
TABLE 54 INDIA STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 130
TABLE 55 INDIA REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 130
TABLE 56 INDIA INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 131
TABLE 57 INDIA STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 131
TABLE 58 INDIA STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 131
TABLE 59 INDIA CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 132
TABLE 60 INDIA STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 132
TABLE 61 INDIA STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 132
TABLE 62 SOUTH KOREA STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 133
TABLE 63 SOUTH KOREA PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 133
TABLE 64 SOUTH KOREA H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 134
TABLE 65 SOUTH KOREA FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 134
TABLE 66 SOUTH KOREA FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 134
TABLE 67 SOUTH KOREA INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 135
TABLE 68 SOUTH KOREA CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 135
TABLE 69 SOUTH KOREA STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 135
TABLE 70 SOUTH KOREA REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 135
TABLE 71 SOUTH KOREA INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 136
TABLE 72 SOUTH KOREA STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 136
TABLE 73 SOUTH KOREA STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 136
TABLE 74 SOUTH KOREA CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 137
TABLE 75 SOUTH KOREA STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 137
TABLE 76 SOUTH KOREA STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 137
TABLE 77 AUSTRALIA STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 138
TABLE 78 AUSTRALIA PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 138
TABLE 79 AUSTRALIA H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 139
TABLE 80 AUSTRALIA FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 139
TABLE 81 AUSTRALIA FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 139
TABLE 82 AUSTRALIA INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 139
TABLE 83 AUSTRALIA CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 140
TABLE 84 AUSTRALIA STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 140
TABLE 85 AUSTRALIA REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 140
TABLE 86 AUSTRALIA INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 141
TABLE 87 AUSTRALIA STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 141
TABLE 88 AUSTRALIA STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 141
TABLE 89 AUSTRALIA CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 142
TABLE 90 AUSTRALIA STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 142
TABLE 91 AUSTRALIA STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 142
TABLE 92 MALAYSIA STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 143
TABLE 93 MALAYSIA PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 143
TABLE 94 MALAYSIA H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 144
TABLE 95 MALAYSIA FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 144
TABLE 96 MALAYSIA FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 144
TABLE 97 MALAYSIA INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 144
TABLE 98 MALAYSIA CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 145
TABLE 99 MALAYSIA STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 145
TABLE 100 MALAYSIA REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 145
TABLE 101 MALAYSIA INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 146
TABLE 102 MALAYSIA STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 146
TABLE 103 MALAYSIA STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 146
TABLE 104 MALAYSIA CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 147
TABLE 105 MALAYSIA STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 147
TABLE 106 MALAYSIA STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 147
TABLE 107 INDONESIA STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 148
TABLE 108 INDONESIA PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 148
TABLE 109 INDONESIA H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 149
TABLE 110 INDONESIA FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 149
TABLE 111 INDONESIA FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 149
TABLE 112 INDONESIA INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 150
TABLE 113 INDONESIA CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 150
TABLE 114 INDONESIA STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 150
TABLE 115 INDONESIA REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 151
TABLE 116 INDONESIA INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 151
TABLE 117 INDONESIA STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 151
TABLE 118 INDONESIA STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 152
TABLE 119 INDONESIA CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 152
TABLE 120 INDONESIA STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 152
TABLE 121 INDONESIA STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 153
TABLE 122 PHILIPPINES STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 154
TABLE 123 PHILIPPINES PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 154
TABLE 124 PHILIPPINES H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 155
TABLE 125 PHILIPPINES FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 155
TABLE 126 PHILIPPINES FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 155
TABLE 127 PHILIPPINES INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 155
TABLE 128 PHILIPPINES CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 156
TABLE 129 PHILIPPINES STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 156
TABLE 130 PHILIPPINES REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 156
TABLE 131 PHILIPPINES INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 157
TABLE 132 PHILIPPINES STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 157
TABLE 133 PHILIPPINES STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 157
TABLE 134 PHILIPPINES CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 158
TABLE 135 PHILIPPINES STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 158
TABLE 136 PHILIPPINES STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 158
TABLE 137 THAILAND STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 159
TABLE 138 THAILAND PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 159
TABLE 139 THAILAND H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 160
TABLE 140 THAILAND FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 160
TABLE 141 THAILAND FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 160
TABLE 142 THAILAND INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 160
TABLE 143 THAILAND CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 161
TABLE 144 THAILAND STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 161
TABLE 145 THAILAND REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 161
TABLE 146 THAILAND INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 162
TABLE 147 THAILAND STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 162
TABLE 148 THAILAND STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 162
TABLE 149 THAILAND CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 163
TABLE 150 THAILAND STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 163
TABLE 151 THAILAND STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 163
TABLE 152 NEW ZEALAND STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 164
TABLE 153 NEW ZEALAND PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 164
TABLE 154 NEW ZEALAND H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 165
TABLE 155 NEW ZEALAND FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 165
TABLE 156 NEW ZEALAND FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 165
TABLE 157 NEW ZEALAND INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 165
TABLE 158 NEW ZEALAND CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 166
TABLE 159 NEW ZEALAND STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 166
TABLE 160 NEW ZEALAND REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 166
TABLE 161 NEW ZEALAND INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 167
TABLE 162 NEW ZEALAND STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 167
TABLE 163 NEW ZEALAND STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 167
TABLE 164 NEW ZEALAND CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 168
TABLE 165 NEW ZEALAND STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 168
TABLE 166 NEW ZEALAND STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 168
TABLE 167 TAIWAN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 169
TABLE 168 TAIWAN PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 169
TABLE 169 TAIWAN H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 170
TABLE 170 TAIWAN FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 170
TABLE 171 TAIWAN FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 170
TABLE 172 TAIWAN INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 170
TABLE 173 TAIWAN CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 171
TABLE 174 TAIWAN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 171
TABLE 175 TAIWAN REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 171
TABLE 176 TAIWAN INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 172
TABLE 177 TAIWAN STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 172
TABLE 178 TAIWAN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 172
TABLE 179 TAIWAN CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 173
TABLE 180 TAIWAN STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 173
TABLE 181 TAIWAN STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 173
TABLE 182 VIETNAM STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 174
TABLE 183 VIETNAM PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 174
TABLE 184 VIETNAM H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 175
TABLE 185 VIETNAM FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 175
TABLE 186 VIETNAM FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 175
TABLE 187 VIETNAM INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 176
TABLE 188 VIETNAM CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 176
TABLE 189 VIETNAM STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 176
TABLE 190 VIETNAM REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 176
TABLE 191 VIETNAM INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 177
TABLE 192 VIETNAM STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND) 177
TABLE 193 VIETNAM STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 177
TABLE 194 VIETNAM CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 178
TABLE 195 VIETNAM STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND) 178
TABLE 196 VIETNAM STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 178
TABLE 197 HONG KONG STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 179
TABLE 198 HONG KONG PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 179
TABLE 199 HONG KONG H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 180
TABLE 200 HONG KONG FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 180
TABLE 201 HONG KONG FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 180
TABLE 202 HONG KONG INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 181
TABLE 203 HONG KONG CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND) 181